Epigenetic changes in diabetes and cardiovascular risk

Circulation Research

Volumn 118, Issue 11, 2016, Pages 1706-1722

  Keating, Samuel T ^a   Plutzky, Jorge ^b   El Osta, Assam ^a,c,d  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

atherosclerosis; cardiovascular diseases; chromatin; diabetes mellitus; epigenenomics

Indexed keywords

GLUCOSE;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CELL PLASTICITY; DIABETES MELLITUS; ENDOTHELIUM CELL; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; IMMUNOCOMPETENT CELL; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE CELL; ANIMAL; CHROMATIN ASSEMBLY AND DISASSEMBLY; DIABETIC ANGIOPATHY; GENETIC EPIGENESIS; GENETICS;

ANIMALS; CHROMATIN ASSEMBLY AND DISASSEMBLY; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; EPIGENESIS, GENETIC; HUMANS;

EID: 84971229320     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.306819     Document Type: Review

References (202)

1. Bliss M, The Discovery of Insulin 2007 25th anniversary ed Chicago University of Chicago Press
2. The Diabetes Control and Complications Trial (DCCT) The DCCT Research Group Design and methodologic considerations for the feasibility phase. Diabetes 1986 35 530 545
3. Epidemiology of Diabetes Interventions and Complications (EDIC) Design, implementation, and preliminary results of a long-Term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 1999 22 99 111
4. Diabetes C, Complications Trial /Epidemiology of Diabetes I, Complications Research G Lachin JM, White NH, Hainsworth DP, Sun W, Cleary PA, Nathan DM, Diabetes C, Complications Trial /Epidemiology of Diabetes I, Complications Research G Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC. Diabetes 2015 64 631 642. doi: 10.2337/db14-0930
5. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998 352 837 853. doi: 10.1016/S0140-6736(98)07019-6
6. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA, 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008 359 1577 1589. doi: 10.1056/NEJMoa0806470
7. Hayward RA, Reaven PD, Wiitala WL, Bahn GD, Reda DJ, Ge L, McCarren M, Duckworth WC, Emanuele NV, VADT Investigators Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. N Engl J Med 2015 372 2197 2206. doi: 10.1056/NEJMoa1414266
8. Duckworth W, Abraira C, Moritz T, VADT Investigators Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009 360 129 139. doi: 10.1056/NEJMoa0808431
9. Patel A, MacMahon S, Chalmers J, ADVANCE Collaborative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008 358 2560 2572. doi: 10.1056/NEJMoa0802987
10. Gaede P, Vedel P, Parving HH, Pedersen O, Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet 1999 353 617 622. doi: 10.1016/S0140-6736(98)07368-1
11. Engerman RL, Kern TS, Progression of incipient diabetic retinopathy during good glycemic control. Diabetes 1987 36 808 812
12. Hammes HP, Klinzing I, Wiegand S, Bretzel RG, Cohen AM, Federlin K, Islet transplantation inhibits diabetic retinopathy in the sucrose-fed diabetic Cohen rat. Invest Ophthalmol Vis Sci 1993 34 2092 2096
13. Brasacchio D, Okabe J, Tikellis C, Balcerczyk A, George P, Baker EK, Calkin AC, Brownlee M, Cooper ME, El-Osta A, Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-Activating epigenetic marks that coexist on the lysine tail. Diabetes 2009 58 1229 1236. doi: 10.2337/db08-1666
14. Sequeira-Mendes J, Gutierrez C, Genome architecture: from linear organisation of chromatin to the 3D assembly in the nucleus [published online ahead of print September 2, 2015] Chromosoma. doi: 10.1007/s00412-015-0538-5. http://link.springer.com/article/10.1007%2Fs00412-015-0538-5
15. Kouzarides T, Chromatin modifications and their function. Cell 2007 128 693 705. doi: 10.1016/j.cell.2007.02.005
16. Keating ST, El-Osta A, Epigenetics and metabolism. Circ Res 2015 116 715 736. doi: 10.1161/CIRCRESAHA.116.303936
17. Guccione E, Bassi C, Casadio F, Martinato F, Cesaroni M, Schuchlautz H, Lüscher B, Amati B, Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive. Nature 2007 449 933 937. doi: 10.1038/nature06166
18. Chang B, Chen Y, Zhao Y, Bruick RK, JMJD6 is a histone arginine demethylase. Science 2007 318 444 447. doi: 10.1126/science.1145801
19. Nakamura T, Mori T, Tada S, Krajewski W, Rozovskaia T, Wassell R, Dubois G, Mazo A, Croce CM, Canaani E, ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol Cell 2002 10 1119 1128
20. Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, Casero RA, Shi Y, Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004 119 941 953. doi: 10.1016/j.cell.2004.12.012
21. Sims RJ 3rd, Chen CF, Santos-Rosa H, Kouzarides T, Patel SS, Reinberg D, Human but not yeast CHD1 binds directly and selectively to histone H3 methylated at lysine 4 via its tandem chromodomains. J Biol Chem 2005 280 41789 41792. doi: 10.1074/jbc.C500395200
22. Flanagan JF, Mi LZ, Chruszcz M, Cymborowski M, Clines KL, Kim Y, Minor W, Rastinejad F, Khorasanizadeh S, Double chromodomains cooperate to recognize the methylated histone H3 tail. Nature 2005 438 1181 1185. doi: 10.1038/nature04290
23. Demers C, Chaturvedi CP, Ranish JA, Juban G, Lai P, Morle F, Aebersold R, Dilworth FJ, Groudine M, Brand M, Activator-mediated recruitment of the MLL2 methyltransferase complex to the beta-globin locus. Mol Cell 2007 27 573 584. doi: 10.1016/j.molcel.2007.06.022
24. Ciccone DN, Su H, Hevi S, Gay F, Lei H, Bajko J, Xu G, Li E, Chen T, KDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints. Nature 2009 461 415 418. doi: 10.1038/nature08315
25. Wysocka J, Swigut T, Xiao H, Milne TA, Kwon SY, Landry J, Kauer M, Tackett AJ, Chait BT, Badenhorst P, Wu C, Allis CD, A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature 2006 442 86 90. doi: 10.1038/nature04815
26. Cho YW, Hong T, Hong S, Guo H, Yu H, Kim D, Guszczynski T, Dressler GR, Copeland TD, Kalkum M, Ge K, PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. J Biol Chem 2007 282 20395 20406. doi: 10.1074/jbc.M701574200
27. Tsukada Y, Fang J, Erdjument-Bromage H, Warren ME, Borchers CH, Tempst P, Zhang Y, Histone demethylation by a family of JmjC domain-containing proteins. Nature 2006 439 811 816. doi: 10.1038/nature04433
28. Shi X, Hong T, Walter KL, ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature 2006 442 96 99. doi: 10.1038/nature04835
29. Klose RJ, Yan Q, Tothova Z, Yamane K, Erdjument-Bromage H, Tempst P, Gilliland DG, Zhang Y, Kaelin WG Jr, The retinoblastoma binding protein RBP2 is an H3K4 demethylase. Cell 2007 128 889 900. doi: 10.1016/j.cell.2007.02.013
30. Liu Y, Subrahmanyam R, Chakraborty T, Sen R, Desiderio S, A plant homeodomain in RAG-2 that binds Hypermethylated lysine 4 of histone H3 is necessary for efficient antigen-receptor-gene rearrangement. Immunity 2007 27 561 571. doi: 10.1016/j.immuni.2007.09.005
31. Fujiki R, Chikanishi T, Hashiba W, Ito H, Takada I, Roeder RG, Kitagawa H, Kato S, GlcNAcylation of a histone methyltransferase in retinoic-Acid-induced granulopoiesis. Nature 2009 459 455 459. doi: 10.1038/nature07954
32. Yamane K, Tateishi K, Klose RJ, Fang J, Fabrizio LA, Erdjument-Bromage H, Taylor-Papadimitriou J, Tempst P, Zhang Y, PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. Mol Cell 2007 25 801 812. doi: 10.1016/j.molcel.2007.03.001
33. Wang H, Cao R, Xia L, Erdjument-Bromage H, Borchers C, Tempst P, Zhang Y, Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase. Mol Cell 2001 8 1207 1217
34. Tahiliani M, Mei P, Fang R, Leonor T, Rutenberg M, Shimizu F, Li J, Rao A, Shi Y, The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation. Nature 2007 447 601 605. doi: 10.1038/nature05823
35. Eom GH, Kim KB, Kim JH, Kim JY, Kim JR, Kee HJ, Kim DW, Choe N, Park HJ, Son HJ, Choi SY, Kook H, Seo SB, Histone methyltransferase SETD3 regulates muscle differentiation. J Biol Chem 2011 286 34733 34742. doi: 10.1074/jbc.M110.203307
36. Lee MG, Norman J, Shilatifard A, Shiekhattar R, Physical and functional association of a trimethyl H3K4 demethylase and Ring6a/MBLR, a polycomb-like protein. Cell 2007 128 877 887. doi: 10.1016/j.cell.2007.02.004
37. Wysocka J, Myers MP, Laherty CD, Eisenman RN, Herr W, Human Sin3 deacetylase and trithorax-related Set1/Ash2 histone H3-K4 methyltransferase are tethered together selectively by the cell-proliferation factor HCF-1. Genes Dev 2003 17 896 911. doi: 10.1101/gad.252103
38. Sinha KM, Yasuda H, Coombes MM, Dent SY, de Crombrugghe B, Regulation of the osteoblast-specific transcription factor Osterix by NO66, a Jumonji family histone demethylase. EMBO J 2010 29 68 79. doi: 10.1038/emboj.2009.332
39. Lee JH, Tate CM, You JS, Skalnik DG, Identification and characterization of the human Set1B histone H3-Lys4 methyltransferase complex. J Biol Chem 2007 282 13419 13428. doi: 10.1074/jbc.M609809200
40. Lee SH, Oshige M, Durant ST, Rasila KK, Williamson EA, Ramsey H, Kwan L, Nickoloff JA, Hromas R, The SET domain protein Metnase mediates foreign DNA integration and links integration to nonhomologous end-joining repair. Proc Natl Acad Sci U S A 2005 102 18075 18080. doi: 10.1073/pnas.0503676102
41. Kim SM, Kee HJ, Eom GH, Choe NW, Kim JY, Kim YS, Kim SK, Kook H, Kook H, Seo SB, Characterization of a novel WHSC1-Associated SET domain protein with H3K4 and H3K27 methyltransferase activity. Biochem Biophys Res Commun 2006 345 318 323. doi: 10.1016/j.bbrc.2006.04.095
42. Tan X, Rotllant J, Li H, De Deyne P, DeDeyne P, Du SJ, SmyD1, a histone methyltransferase, is required for myofibril organization and muscle contraction in zebrafish embryos. Proc Natl Acad Sci U S A 2006 103 2713 2718. doi: 10.1073/pnas.0509503103
43. Abu-Farha M, Lambert JP, Al-Madhoun AS, Elisma F, Skerjanc IS, Figeys D, The tale of two domains: proteomics and genomics analysis of SMYD2, a new histone methyltransferase. Mol Cell Proteomics 2008 7 560 572. doi: 10.1074/mcp.M700271-MCP200
44. Hamamoto R, Furukawa Y, Morita M, Iimura Y, Silva FP, Li M, Yagyu R, Nakamura Y, SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells. Nat Cell Biol 2004 6 731 740. doi: 10.1038/ncb1151
45. Pal S, Vishwanath SN, Erdjument-Bromage H, Tempst P, Sif S, Human SWI/SNF-Associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes. Mol Cell Biol 2004 24 9630 9645. doi: 10.1128/MCB.24.21.9630-9645.2004
46. Tachibana M, Sugimoto K, Fukushima T, Shinkai Y, Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3. J Biol Chem 2001 276 25309 25317. doi: 10.1074/jbc.M101914200
47. Zhu Z, Wang Y, Li X, Wang Y, Xu L, Wang X, Sun T, Dong X, Chen L, Mao H, Yu Y, Li J, Li J, Chen PA, Chen CD, PHF8 is a histone H3K9me2 demethylase regulating rRNA synthesis. Cell Res 2010 20 794 801. doi: 10.1038/cr.2010.75
48. Eskeland R, Eberharter A, Imhof A, HP1 binding to chromatin methylated at H3K9 is enhanced by auxiliary factors. Mol Cell Biol 2007 27 453 465. doi: 10.1128/MCB.01576-06
49. Martin C, Cao R, Zhang Y, Substrate preferences of the EZH2 histone methyltransferase complex. J Biol Chem 2006 281 8365 8370. doi: 10.1074/jbc.M513425200
50. Rothbart SB, Krajewski K, Nady N, Tempel W, Xue S, Badeaux AI, Barsyte-Lovejoy D, Martinez JY, Bedford MT, Fuchs SM, Arrowsmith CH, Strahl BD, Association of UHRF1 with methylated H3K9 directs the maintenance of DNA methylation. Nat Struct Mol Biol 2012 19 1155 1160. doi: 10.1038/nsmb.2391
51. Schultz DC, Ayyanathan K, Negorev D, Maul GG, Rauscher FJ 3rd, SETDB1: A novel KAP-1-Associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev 2002 16 919 932. doi: 10.1101/gad.973302
52. Yamane K, Toumazou C, Tsukada Y, Erdjument-Bromage H, Tempst P, Wong J, Zhang Y, JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor. Cell 2006 125 483 495. doi: 10.1016/j.cell.2006.03.027
53. Vermeulen M, Eberl HC, Matarese F, Marks H, Denissov S, Butter F, Lee KK, Olsen JV, Hyman AA, Stunnenberg HG, Mann M, Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers. Cell 2010 142 967 980. doi: 10.1016/j.cell.2010.08.020
54. Falandry C, Fourel G, Galy V, Ristriani T, Horard B, Bensimon E, Salles G, Gilson E, Magdinier F, CLLD8/KMT1F is a lysine methyltransferase that is important for chromosome segregation. J Biol Chem 2010 285 20234 20241. doi: 10.1074/jbc.M109.052399
55. Bua DJ, Kuo AJ, Cheung P, Liu CL, Migliori V, Espejo A, Casadio F, Bassi C, Amati B, Bedford MT, Guccione E, Gozani O, Epigenome microarray platform for proteome-wide dissection of chromatin-signaling networks. PLoS One 2009 4 e6789. doi: 10.1371/journal.pone.0006789
56. Lachner M, O'Carroll D, Rea S, Mechtler K, Jenuwein T, Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 2001 410 116 120. doi: 10.1038/35065132
57. Whetstine JR, Nottke A, Lan F, Huarte M, Smolikov S, Chen Z, Spooner E, Li E, Zhang G, Colaiacovo M, Shi Y, Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 2006 125 467 481. doi: 10.1016/j.cell.2006.03.028
58. Ait-Si-Ali S, Guasconi V, Fritsch L, Yahi H, Sekhri R, Naguibneva I, Robin P, Cabon F, Polesskaya A, Harel-Bellan A, A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells. The EMBO journal 2004 23 605 15
59. Kuzmichev A, Nishioka K, Erdjument-Bromage H, Tempst P, Reinberg D, Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. Genes Dev 2002 16 2893 2905. doi: 10.1101/gad.1035902
60. Ananthanarayanan M, Li S, Balasubramaniyan N, Suchy FJ, Walsh MJ, Ligand-dependent activation of the farnesoid X-receptor directs arginine methylation of histone H3 by CARM1. J Biol Chem 2004 279 54348 54357. doi: 10.1074/jbc.M410021200
61. Yang Y, Lu Y, Espejo A, Wu J, Xu W, Liang S, Bedford MT, TDRD3 is an effector molecule for arginine-methylated histone marks. Mol Cell 2010 40 1016 1023. doi: 10.1016/j.molcel.2010.11.024
62. Bernstein E, Duncan EM, Masui O, Gil J, Heard E, Allis CD, Mouse polycomb proteins bind differentially to methylated histone H3 and RNA and are enriched in facultative heterochromatin. Mol Cell Biol 2006 26 2560 2569. doi: 10.1128/MCB.26.7.2560-2569.2006
63. Margueron R, Li G, Sarma K, Blais A, Zavadil J, Woodcock CL, Dynlacht BD, Reinberg D, Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms. Mol Cell 2008 32 503 518. doi: 10.1016/j.molcel.2008.11.004
64. Lan F, Bayliss PE, Rinn JL, Whetstine JR, Wang JK, Chen S, Iwase S, Alpatov R, Issaeva I, Canaani E, Roberts TM, Chang HY, Shi Y, A histone H3 lysine 27 demethylase regulates animal posterior development. Nature 2007 449 689 694. doi: 10.1038/nature06192
65. De Santa F, Totaro MG, Prosperini E, Notarbartolo S, Testa G, Natoli G, The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 2007 130 1083 1094. doi: 10.1016/j.cell.2007.08.019
66. Tsukada Y, Ishitani T, Nakayama KI, KDM7 is a dual demethylase for histone H3 Lys 9 and Lys 27 and functions in brain development. Genes Dev 2010 24 432 437. doi: 10.1101/gad.1864410
67. Sun XJ, Wei J, Wu XY, Hu M, Wang L, Wang HH, Zhang QH, Chen SJ, Huang QH, Chen Z, Identification and characterization of a novel human histone H3 lysine 36-specific methyltransferase. J Biol Chem 2005 280 35261 35271. doi: 10.1074/jbc.M504012200
68. Luco RF, Pan Q, Tominaga K, Blencowe BJ, Pereira-Smith OM, Misteli T, Regulation of alternative splicing by histone modifications. Science 2010 327 996 1000. doi: 10.1126/science.1184208
69. Brown MA, Sims RJ 3rd, Gottlieb PD, Tucker PW, Identification and characterization of Smyd2: A split SET/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase complex. Mol Cancer 2006 5 26. doi: 10.1186/1476-4598-5-26
70. Hsia DA, Tepper CG, Pochampalli MR, Hsia EY, Izumiya C, Huerta SB, Wright ME, Chen HW, Kung HJ, Izumiya Y, KDM8, a H3K36me2 histone demethylase that acts in the cyclin A1 coding region to regulate cancer cell proliferation. Proc Natl Acad Sci U S A 2010 107 9671 9676. doi: 10.1073/pnas.1000401107
71. Feng Q, Wang H, Ng HH, Erdjument-Bromage H, Tempst P, Struhl K, Zhang Y, Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain. Curr Biol 2002 12 1052 1058
72. Huyen Y, Zgheib O, Ditullio RA Jr, Gorgoulis VG, Zacharatos P, Petty TJ, Sheston EA, Mellert HS, Stavridi ES, Halazonetis TD, Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks. Nature 2004 432 406 411. doi: 10.1038/nature03114
73. Strahl BD, Briggs SD, Brame CJ, Caldwell JA, Koh SS, Ma H, Cook RG, Shabanowitz J, Hunt DF, Stallcup MR, Allis CD, Methylation of histone H4 at arginine 3 occurs in vivo and is mediated by the nuclear receptor coactivator PRMT1. Curr Biol 2001 11 996 1000
74. Lee JH, Cook JR, Yang ZH, Mirochnitchenko O, Gunderson SI, Felix AM, Herth N, Hoffmann R, Pestka S, PRMT7, a new protein arginine methyltransferase that synthesizes symmetric dimethylarginine. J Biol Chem 2005 280 3656 3664. doi: 10.1074/jbc.M405295200
75. Zhao Q, Rank G, Tan YT, Li H, Moritz RL, Simpson RJ, Cerruti L, Curtis DJ, Patel DJ, Allis CD, Cunningham JM, Jane SM, PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing. Nat Struct Mol Biol 2009 16 304 311. doi: 10.1038/nsmb.1568
76. Chinenov Y, Sacta MA, Cruz AR, Rogatsky I, GRIP1-Associated SET-domain methyltransferase in glucocorticoid receptor target gene expression. Proc Natl Acad Sci U S A 2008 105 20185 20190. doi: 10.1073/pnas.0810863105
77. Botuyan MV, Lee J, Ward IM, Kim JE, Thompson JR, Chen J, Mer G, Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair. Cell 2006 127 1361 1373. doi: 10.1016/j.cell.2006.10.043
78. Kapoor-Vazirani P, Kagey JD, Vertino PM, SUV420H2-mediated H4K20 trimethylation enforces RNA polymerase II promoter-proximal pausing by blocking hMOF-dependent H4K16 acetylation. Mol Cell Biol 2011 31 1594 1609. doi: 10.1128/MCB.00524-10
79. Trojer P, Li G, Sims RJ III, Vaquero A, Kalakonda N, Boccuni P, Lee D, Erdjument-Bromage H, Tempst P, Nimer SD, Wang YH, Reinberg D, L3MBTL1, a histone-methylation-dependent chromatin lock. Cell 2007 129 915 928. doi: 10.1016/j.cell.2007.03.048
80. Nishioka K, Rice JC, Sarma K, Erdjument-Bromage H, Werner J, Wang Y, Chuikov S, Valenzuela P, Tempst P, Steward R, Lis JT, Allis CD, Reinberg D, PR-Set7 is a nucleosome-specific methyltransferase that modifies lysine 20 of histone H4 and is associated with silent chromatin. Mol Cell 2002 9 1201 1213
81. Yen RW, Vertino PM, Nelkin BD, Yu JJ, el-Deiry W, Cumaraswamy A, Lennon GG, Trask BJ, Celano P, Baylin SB, Isolation and characterization of the cDNA encoding human DNA methyltransferase. Nucleic Acids Res 1992 20 2287 2291
82. Guo JU, Su Y, Zhong C, Ming GL, Song H, Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 2011 145 423 434. doi: 10.1016/j.cell.2011.03.022
83. Lewis JD, Meehan RR, Henzel WJ, Maurer-Fogy I, Jeppesen P, Klein F, Bird A, Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 1992 69 905 914
84. Okano M, Xie S, Li E, Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet 1998 19 219 220. doi: 10.1038/890
85. Ko M, Huang Y, Jankowska AM, Pape UJ, Tahiliani M, Bandukwala HS, An J, Lamperti ED, Koh KP, Ganetzky R, Liu XS, Aravind L, Agarwal S, Maciejewski JP, Rao A, Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 2010 468 839 43
86. Ohki I, Shimotake N, Fujita N, Jee J, Ikegami T, Nakao M, Shirakawa M, Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA. Cell 2001 105 487 497
87. Shen L, Inoue A, He J, Liu Y, Lu F, Zhang Y, Tet3 and DNA replication mediate demethylation of both the maternal and paternal genomes in mouse zygotes. Cell Stem Cell 2014 15 459 470. doi: 10.1016/j.stem.2014.09.002
88. Hendrich B, Bird A, Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol 1998 18 6538 6547
89. Bird A, DNA methylation patterns and epigenetic memory. Genes Dev 2002 16 6 21. doi: 10.1101/gad.947102
90. Baubec T, Schübeler D, Genomic patterns and context specific interpretation of DNA methylation. Curr Opin Genet Dev 2014 25 85 92. doi: 10.1016/j.gde.2013.11.015
91. Iguchi-Ariga SM, Schaffner W, CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation. Genes Dev 1989 3 612 619
92. Klose RJ, Bird AP, Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 2006 31 89 97. doi: 10.1016/j.tibs.2005.12.008
93. Torchy MP, Hamiche A, Klaholz BP, Structure and function insights into the NuRD chromatin remodeling complex. Cell Mol Life Sci 2015 72 2491 2507. doi: 10.1007/s00018-015-1880-8
94. Meehan RR, Lewis JD, McKay S, Kleiner EL, Bird AP, Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell 1989 58 499 507
95. Clouaire T, Stancheva I, Methyl-CpG binding proteins: specialized transcriptional repressors or structural components of chromatin? Cell Mol Life Sci 2008 65 1509 1522. doi: 10.1007/s00018-008-7324-y.
96. Lombardi LM, Baker SA, Zoghbi HY, MECP2 disorders: from the clinic to mice and back. J Clin Invest 2015 125 2914 2923. doi: 10.1172/JCI78167
97. Jones PA, Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 2012 13 484 492. doi: 10.1038/nrg3230
98. Schübeler D, Function and information content of DNA methylation. Nature 2015 517 321 326. doi: 10.1038/nature14192
99. Breiling A, Lyko F, Epigenetic regulatory functions of DNA modifications: 5-methylcytosine and beyond. Epigenetics Chromatin 2015 8 24. doi: 10.1186/s13072-015-0016-6
100. Raiber EA, Beraldi D, Ficz G, Burgess HE, Branco MR, Murat P, Oxley D, Booth MJ, Reik W, Balasubramanian S, Genome-wide distribution of 5-formylcytosine in embryonic stem cells is associated with transcription and depends on thymine DNA glycosylase. Genome Biol 2012 13 R69. doi: 10.1186/gb-2012-13-8-r69
101. Song CX, Szulwach KE, Dai Q, Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming. Cell 2013 153 678 691. doi: 10.1016/j.cell.2013.04.001
102. Choi I, Kim R, Lim HW, Kaestner KH, Won KJ, 5-hydroxymethylcytosine represses the activity of enhancers in embryonic stem cells: A new epigenetic signature for gene regulation. BMC Genomics 2014 15 670. doi: 10.1186/1471-2164-15-670
103. Kundaje A, Meuleman W, Ernst J, Integrative analysis of 111 reference human epigenomes. Nature 2015 518 317 30
104. Geybels MS, Zhao S, Wong CJ, Bibikova M, Klotzle B, Wu M, Ostrander EA, Fan JB, Feng Z, Stanford JL, Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue. Prostate 2015 75 1941 1950. doi: 10.1002/pros.23093
105. Hannum G, Guinney J, Zhao L, Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell 2013 49 359 367. doi: 10.1016/j.molcel.2012.10.016
106. Marioni RE, Shah S, McRae AF, DNA methylation age of blood predicts all-cause mortality in later life. Genome Biol 2015 16 25. doi: 10.1186/s13059-015-0584-6
107. Keating ST, El-Osta A, Transcriptional regulation by the Set7 lysine methyltransferase. Epigenetics 2013 8 361 372. doi: 10.4161/epi.24234
108. Schmidt SV, Krebs W, Ulas T, Xue J, Baßler K, Günther P, Hardt AL, Schultze H, Sander J, Klee K, Theis H, Kraut M, Beyer M, Schultze JL, The transcriptional regulator network of human inflammatory macrophages is defined by open chromatin. Cell Res 2016 26 151 170. doi: 10.1038/cr.2016.1
109. Wu H, Zhao M, Yoshimura A, Chang C, Lu Q, Critical link between epigenetics and transcription factors in the induction of autoimmunity: A comprehensive review [published online ahead of print March 11, 2016] Clin Rev Allergy Immunol. doi: 10.1007/s12016-016-8534-y. http://link.springer.com/article/10.1007%2Fs12016-016-8534-y.
110. Bannister AJ, Kouzarides T, Regulation of chromatin by histone modifications. Cell Res 2011 21 381 395. doi: 10.1038/cr.2011.22
111. Montgomery DC, Sorum AW, Guasch L, Nicklaus MC, Meier JL, Metabolic regulation of histone acetyltransferases by endogenous acyl-CoA cofactors. Chem Biol 2015 22 1030 1039. doi: 10.1016/j.chembiol.2015.06.015
112. Masri S, Orozco-Solis R, Aguilar-Arnal L, Cervantes M, Sassone-Corsi P, Coupling circadian rhythms of metabolism and chromatin remodelling. Diabetes Obes Metab 2015 17 SUPPL 1 17 22. doi: 10.1111/dom.12509
113. Petty E, Pillus L, Balancing chromatin remodeling and histone modifications in transcription. Trends Genet 2013 29 621 629. doi: 10.1016/j.tig.2013.06.006
114. Lalonde ME, Cheng X, Côté J, Histone target selection within chromatin: An exemplary case of teamwork. Genes Dev 2014 28 1029 1041. doi: 10.1101/gad.236331.113
115. Steward MM, Lee JS, O'Donovan A, Wyatt M, Bernstein BE, Shilatifard A, Molecular regulation of H3K4 trimethylation by ASH2L, a shared subunit of MLL complexes. Nat Struct Mol Biol 2006 13 852 854. doi: 10.1038/nsmb1131
116. Dou Y, Milne TA, Ruthenburg AJ, Lee S, Lee JW, Verdine GL, Allis CD, Roeder RG, Regulation of MLL1 H3K4 methyltransferase activity by its core components. Nat Struct Mol Biol 2006 13 713 719. doi: 10.1038/nsmb1128
117. Xue Y, Wong J, Moreno GT, Young MK, Côté J, Wang W, NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol Cell 1998 2 851 861
118. Mathiyalagan P, Okabe J, Chang L, Su Y, Du XJ, El-Osta A, The primary microRNA-208b interacts with Polycomb-group protein, Ezh2, to regulate gene expression in the heart. Nucleic Acids Res 2014 42 790 803. doi: 10.1093/nar/gkt896
119. Patel DJ, Wang Z, Readout of epigenetic modifications. Annu Rev Biochem 2013 82 81 118. doi: 10.1146/annurev-biochem-072711-165700
120. Filippakopoulos P, Knapp S, Targeting bromodomains: epigenetic readers of lysine acetylation. Nat Rev Drug Discov 2014 13 337 356. doi: 10.1038/nrd4286
121. Shi J, Vakoc CR, The mechanisms behind the therapeutic activity of BET bromodomain inhibition. Mol Cell 2014 54 728 736. doi: 10.1016/j.molcel.2014.05.016
122. Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, Rahl PB, Lee TI, Young RA, Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 2013 153 307 319. doi: 10.1016/j.cell.2013.03.035
123. Quang DX, Erdos MR, Parker SC, Collins FS, Motif signatures in stretch enhancers are enriched for disease-Associated genetic variants. Epigenetics Chromatin 2015 8 23. doi: 10.1186/s13072-015-0015-7
124. Ross R, Atherosclerosis-An inflammatory disease. N Engl J Med 1999 340 115 126. doi: 10.1056/NEJM199901143400207
125. Piga R, Naito Y, Kokura S, Handa O, Yoshikawa T, Short-Term high glucose exposure induces monocyte-endothelial cells adhesion and transmigration by increasing VCAM-1 and MCP-1 expression in human aortic endothelial cells. Atherosclerosis 2007 193 328 334. doi: 10.1016/j.atherosclerosis.2006.09.016
126. Suzuki LA, Poot M, Gerrity RG, Bornfeldt KE, Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levels. Diabetes 2001 50 851 860
127. Parathath S, Grauer L, Huang LS, Sanson M, Distel E, Goldberg IJ, Fisher EA, Diabetes adversely affects macrophages during atherosclerotic plaque regression in mice. Diabetes 2011 60 1759 1769. doi: 10.2337/db10-0778
128. Marian AJ, Belmont J, Strategic approaches to unraveling genetic causes of cardiovascular diseases. Circ Res 2011 108 1252 1269. doi: 10.1161/CIRCRESAHA.110.236067
129. Zaina S, Heyn H, Carmona FJ, Varol N, Sayols S, Condom E, Ramírez-Ruz J, Gomez A, Gonçalves I, Moran S, Esteller M, DNA methylation map of human atherosclerosis. Circ Cardiovasc Genet 2014 7 692 700. doi: 10.1161/CIRCGENETICS.113.000441
130. Valencia-Morales Mdel P, Zaina S, Heyn H, The DNA methylation drift of the atherosclerotic aorta increases with lesion progression. BMC Med Genomics 2015 8 7. doi: 10.1186/s12920-015-0085-1
131. ENCODE Project Consortium An integrated encyclopedia of DNA elements in the human genome. Nature 2012 489 57 74. doi: 10.1038/nature11247
132. Nomoto H, Miyoshi H, Furumoto T, Oba K, Tsutsui H, Miyoshi A, Kondo T, Tsuchida K, Atsumi T, Manda N, Kurihara Y, Aoki S, SAIS Study Group A Comparison of the Effects of the GLP-1 Analogue Liraglutide and Insulin Glargine on Endothelial Function and Metabolic Parameters: A Randomized, Controlled Trial Sapporo Athero-Incretin Study 2 (SAIS2). PLoS One 2015 10 e0135854. doi: 10.1371/journal.pone.0135854
133. Sukmawati D, Tanaka R, Introduction to next generation of endothelial progenitor cell therapy: A promise in vascular medicine. Am J Transl Res 2015 7 411 421
134. Pirola L, Balcerczyk A, Tothill RW, Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells. Genome Res 2011 21 1601 1615. doi: 10.1101/gr.116095.110
135. El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, Cooper ME, Brownlee M, Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 2008 205 2409 2417. doi: 10.1084/jem.20081188
136. Okabe J, Orlowski C, Balcerczyk A, Tikellis C, Thomas MC, Cooper ME, El-Osta A, Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells. Circ Res 2012 110 1067 1076. doi: 10.1161/CIRCRESAHA.112.266171
137. Keating ST, Ziemann M, Okabe J, Khan AW, Balcerczyk A, El-Osta A, Deep sequencing reveals novel Set7 networks. Cell Mol Life Sci 2014 71 4471 4486. doi: 10.1007/s00018-014-1651-y.
138. Brown JD, Lin CY, Duan Q, NF-κB directs dynamic super enhancer formation in inflammation and atherogenesis. Mol Cell 2014 56 219 231. doi: 10.1016/j.molcel.2014.08.024
139. Pott S, Lieb JD, What are super-enhancers? Nat Genet 2015 47 8 12. doi: 10.1038/ng.3167
140. Parker SC, Stitzel ML, Taylor DL, Orozco JM, Erdos MR, Akiyama JA, van Bueren KL, Chines PS, Narisu N, Program NCS, Black BL, Visel A, Pennacchio LA, Collins FS, National Institutes of Health Intramural Sequencing Center Comparative Sequencing Program A and Authors NCSP. Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants. Proc Natl Acad Sci U S A 2013 110 17921 17926
141. Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-André V, Sigova AA, Hoke HA, Young RA, Super-enhancers in the control of cell identity and disease. Cell 2013 155 934 947. doi: 10.1016/j.cell.2013.09.053
142. Nicodeme E, Jeffrey KL, Schaefer U, Suppression of inflammation by a synthetic histone mimic. Nature 2010 468 1119 1123. doi: 10.1038/nature09589
143. Denis GV, Nikolajczyk BS, Schnitzler GR, An emerging role for bromodomain-containing proteins in chromatin regulation and transcriptional control of adipogenesis. FEBS Lett 2010 584 3260 3268. doi: 10.1016/j.febslet.2010.05.030
144. Meloche J, Potus F, Vaillancourt M, Bromodomain-containing protein 4: the epigenetic origin of pulmonary arterial hypertension. Circ Res 2015 117 525 535. doi: 10.1161/CIRCRESAHA.115.307004
145. Jahagirdar R, Zhang H, Azhar S, Tobin J, Attwell S, Yu R, Wu J, McLure KG, Hansen HC, Wagner GS, Young PR, Srivastava RA, Wong NC, Johansson J, A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice. Atherosclerosis 2014 236 91 100. doi: 10.1016/j.atherosclerosis.2014.06.008
146. Wang B, Zhang M, Takayama T, Shi X, Roenneburg DA, Kent KC, Guo LW, BET Bromodomain Blockade Mitigates Intimal Hyperplasia in Rat Carotid Arteries. EBioMedicine 2015 2 1650 1661. doi: 10.1016/j.ebiom.2015.09.045
147. Sanchez R, Meslamani J, Zhou MM, The bromodomain: from epigenome reader to druggable target. Biochim Biophys Acta 2014 1839 676 685. doi: 10.1016/j.bbagrm.2014.03.011
148. Anand P, Brown JD, Lin CY, Qi J, Zhang R, Artero PC, Alaiti MA, Bullard J, Alazem K, Margulies KB, Cappola TP, Lemieux M, Plutzky J, Bradner JE, Haldar SM, BET bromodomains mediate transcriptional pause release in heart failure. Cell 2013 154 569 582. doi: 10.1016/j.cell.2013.07.013
149. Brownlee M, Biochemistry and molecular cell biology of diabetic complications. Nature 2001 414 813 820. doi: 10.1038/414813a.
150. Ihnat MA, Thorpe JE, Kamat CD, Szabó C, Green DE, Warnke LA, Lacza Z, Cselenyák A, Ross K, Shakir S, Piconi L, Kaltreider RC, Ceriello A, Reactive oxygen species mediate a cellular 'memory' of high glucose stress signalling. Diabetologia 2007 50 1523 1531. doi: 10.1007/s00125-007-0684-2
151. Paneni F, Volpe M, Lüscher TF, Cosentino F, SIRT1, p66(Shc), and Set7/9 in vascular hyperglycemic memory: bringing all the strands together. Diabetes 2013 62 1800 1807. doi: 10.2337/db12-1648
152. Paneni F, Mocharla P, Akhmedov A, Costantino S, Osto E, Volpe M, Lüscher TF, Cosentino F, Gene silencing of the mitochondrial adaptor p66(Shc) suppresses vascular hyperglycemic memory in diabetes. Circ Res 2012 111 278 289. doi: 10.1161/CIRCRESAHA.112.266593
153. Zhou S, Chen HZ, Wan YZ, Zhang QJ, Wei YS, Huang S, Liu JJ, Lu YB, Zhang ZQ, Yang RF, Zhang R, Cai H, Liu DP, Liang CC, Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction. Circ Res 2011 109 639 648. doi: 10.1161/CIRCRESAHA.111.243592
154. Leung A, Trac C, Jin W, Lanting L, Akbany A, Sætrom P, Schones DE, Natarajan R, Novel long noncoding RNAs are regulated by angiotensin II in vascular smooth muscle cells. Circ Res 2013 113 266 278. doi: 10.1161/CIRCRESAHA.112.300849
155. Villeneuve LM, Reddy MA, Lanting LL, Wang M, Meng L, Natarajan R, Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc Natl Acad Sci U S A 2008 105 9047 9052. doi: 10.1073/pnas.0803623105
156. Villeneuve LM, Kato M, Reddy MA, Wang M, Lanting L, Natarajan R, Enhanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db/db mice lead to increased inflammatory gene expression by targeting the histone methyltransferase Suv39h1. Diabetes 2010 59 2904 2915. doi: 10.2337/db10-0208
157. Beamish JA, He P, Kottke-Marchant K, Marchant RE, Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering. Tissue Eng Part B Rev 2010 16 467 491. doi: 10.1089/ten.TEB.2009.0630
158. Kocher O, Gabbiani F, Gabbiani G, Reidy MA, Cokay MS, Peters H, Hüttner I, Phenotypic features of smooth muscle cells during the evolution of experimental carotid artery intimal thickening. Biochemical and morphologic studies. Lab Invest 1991 65 459 470
159. Schwartz SM, Campbell GR, Campbell JH, Replication of smooth muscle cells in vascular disease. Circ Res 1986 58 427 444
160. Sobue K, Hayashi K, Nishida W, Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation. Mol Cell Biochem 1999 190 105 118
161. Liu R, Leslie KL, Martin KA, Epigenetic regulation of smooth muscle cell plasticity. Biochim Biophys Acta 2015 1849 448 453. doi: 10.1016/j.bbagrm.2014.06.004
162. McDonald OG, Wamhoff BR, Hoofnagle MH, Owens GK, Control of SRF binding to CArG box chromatin regulates smooth muscle gene expression in vivo. J Clin Invest 2006 116 36 48. doi: 10.1172/JCI26505
163. Liu R, Jin Y, Tang WH, Qin L, Zhang X, Tellides G, Hwa J, Yu J, Martin KA, Ten-eleven translocation-2 (TET2) is a master regulator of smooth muscle cell plasticity. Circulation 2013 128 2047 2057. doi: 10.1161/CIRCULATIONAHA.113.002887
164. Feil S, Fehrenbacher B, Lukowski R, Essmann F, Schulze-Osthoff K, Schaller M, Feil R, Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis. Circ Res 2014 115 662 667. doi: 10.1161/CIRCRESAHA.115.304634
165. Swirski FK, Nahrendorf M, Do vascular smooth muscle cells differentiate to macrophages in atherosclerotic lesions? Circ Res 2014 115 605 606. doi: 10.1161/CIRCRESAHA.114.304925
166. Miao F, Chen Z, Genuth S, Paterson A, Zhang L, Wu X, Li SM, Cleary P, Riggs A, Harlan DM, Lorenzi G, Kolterman O, Sun W, Lachin JM, Natarajan R, DCCT/EDIC Research Group Evaluating the role of epigenetic histone modifications in the metabolic memory of type 1 diabetes. Diabetes 2014 63 1748 1762. doi: 10.2337/db13-1251
167. Paneni F, Costantino S, Battista R, Castello L, Capretti G, Chiandotto S, Scavone G, Villano A, Pitocco D, Lanza G, Volpe M, Lüscher TF, Cosentino F, Adverse epigenetic signatures by histone methyltransferase Set7 contribute to vascular dysfunction in patients with type 2 diabetes mellitus. Circ Cardiovasc Genet 2015 8 150 158. doi: 10.1161/CIRCGENETICS.114.000671
168. Li Y, Reddy MA, Miao F, Shanmugam N, Yee JK, Hawkins D, Ren B, Natarajan R, Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kappaB-dependent inflammatory genes. Relevance to diabetes and inflammation. J Biol Chem 2008 283 26771 26781. doi: 10.1074/jbc.M802800200
169. Saeed S, Quintin J, Kerstens HH, Epigenetic programming of monocyte-To-macrophage differentiation and trained innate immunity. Science 2014 345 1251086. doi: 10.1126/science.1251086
170. Pena OM, Pistolic J, Raj D, Fjell CD, Hancock RE, Endotoxin tolerance represents a distinctive state of alternative polarization (M2) in human mononuclear cells. J Immunol 2011 186 7243 7254. doi: 10.4049/jimmunol.1001952
171. Foster SL, Hargreaves DC, Medzhitov R, Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 2007 447 972 978. doi: 10.1038/nature05836
172. Ostuni R, Piccolo V, Barozzi I, Polletti S, Termanini A, Bonifacio S, Curina A, Prosperini E, Ghisletti S, Natoli G, Latent enhancers activated by stimulation in differentiated cells. Cell 2013 152 157 171. doi: 10.1016/j.cell.2012.12.018
173. Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD, Barrera LO, Van Calcar S, Qu C, Ching KA, Wang W, Weng Z, Green RD, Crawford GE, Ren B, Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 2007 39 311 318. doi: 10.1038/ng1966
174. Gosselin D, Link VM, Romanoski CE, Fonseca GJ, Eichenfield DZ, Spann NJ, Stender JD, Chun HB, Garner H, Geissmann F, Glass CK, Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell 2014 159 1327 1340. doi: 10.1016/j.cell.2014.11.023
175. Jayashree B, Bibin YS, Prabhu D, Shanthirani CS, Gokulakrishnan K, Lakshmi BS, Mohan V, Balasubramanyam M, Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes. Mol Cell Biochem 2014 388 203 210. doi: 10.1007/s11010-013-1911-4
176. Aravindhan V, Mohan V, Arunkumar N, Sandhya S, Babu S, Chronic Endotoxemia in Subjects with Type-1 Diabetes Is Seen Much before the Onset of Microvascular Complications. PLoS One 2015 10 e0137618. doi: 10.1371/journal.pone.0137618
177. Kiechl S, Egger G, Mayr M, Wiedermann CJ, Bonora E, Oberhollenzer F, Muggeo M, Xu Q, Wick G, Poewe W, Willeit J, Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 2001 103 1064 1070
178. Ostos MA, Recalde D, Zakin MM, Scott-Algara D, Implication of natural killer T cells in atherosclerosis development during a LPS-induced chronic inflammation. FEBS Lett 2002 519 23 29
179. Devaraj S, Glaser N, Griffen S, Wang-Polagruto J, Miguelino E, Jialal I, Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes 2006 55 774 779
180. Bradshaw EM, Raddassi K, Elyaman W, Orban T, Gottlieb PA, Kent SC, Hafler DA, Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells. J Immunol 2009 183 4432 4439. doi: 10.4049/jimmunol.0900576
181. Deshmane SL, Kremlev S, Amini S, Sawaya BE, Monocyte chemoattractant protein-1 (MCP-1): An overview. J Interferon Cytokine Res 2009 29 313 326. doi: 10.1089/jir.2008.0027
182. Abbas A, Aukrust P, Russell D, Krohg-Sørensen K, Almås T, Bundgaard D, Bjerkeli V, Sagen EL, Michelsen AE, Dahl TB, Holm S, Ueland T, Skjelland M, Halvorsen B, Matrix metalloproteinase 7 is associated with symptomatic lesions and adverse events in patients with carotid atherosclerosis. PLoS One 2014 9 e84935. doi: 10.1371/journal.pone.0084935
183. Gough PJ, Gomez IG, Wille PT, Raines EW, Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J Clin Invest 2006 116 59 69. doi: 10.1172/JCI25074
184. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT, Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation 1994 90 775 778
185. Bekkering S, Quintin J, Joosten LA, van der Meer JW, Netea MG, Riksen NP, Oxidized low-density lipoprotein induces long-Term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes. Arterioscler Thromb Vasc Biol 2014 34 1731 1738. doi: 10.1161/ATVBAHA.114.303887
186. Bekkering S, Joosten LA, van der Meer JW, Netea MG, Riksen NP, The epigenetic memory of monocytes and macrophages as a novel drug target in atherosclerosis. Clin Ther 2015 37 914 923. doi: 10.1016/j.clinthera.2015.01.008
187. McKinsey TA, Therapeutic potential for HDAC inhibitors in the heart. Annu Rev Pharmacol Toxicol 2012 52 303 319. doi: 10.1146/annurev-pharmtox-010611-134712
188. Findeisen HM, Gizard F, Zhao Y, Qing H, Heywood EB, Jones KL, Cohn D, Bruemmer D, Epigenetic regulation of vascular smooth muscle cell proliferation and neointima formation by histone deacetylase inhibition. Arterioscler Thromb Vasc Biol 2011 31 851 860. doi: 10.1161/ATVBAHA.110.221952
189. Neele AE, Van den Bossche J, Hoeksema MA, de Winther MP, Epigenetic pathways in macrophages emerge as novel targets in atherosclerosis. Eur J Pharmacol 2015 763 79 89. doi: 10.1016/j.ejphar.2015.03.101
190. Pandey D, Sikka G, Bergman Y, Kim JH, Ryoo S, Romer L, Berkowitz D, Transcriptional regulation of endothelial arginase 2 by histone deacetylase 2. Arterioscler Thromb Vasc Biol 2014 34 1556 1566. doi: 10.1161/ATVBAHA.114.303685
191. Hoeksema MA, Gijbels MJ, Van den Bossche J, Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions. EMBO Mol Med 2014 6 1124 1132. doi: 10.15252/emmm.201404170
192. Van den Bossche J, Neele AE, Hoeksema MA, de Heij F, Boshuizen MC, van der Velden S, de Boer VC, Reedquist KA, de Winther MP, Inhibiting epigenetic enzymes to improve atherogenic macrophage functions. Biochem Biophys Res Commun 2014 455 396 402. doi: 10.1016/j.bbrc.2014.11.029
193. Barsyte-Lovejoy D, Li F, Oudhoff MJ, ®-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells. Proc Natl Acad Sci U S A 2014 111 12853 12858. doi: 10.1073/pnas.1407358111
194. He S, Owen DR, Jelinsky SA, Lin LL, Lysine Methyltransferase SETD7 (SET7/9) Regulates ROS Signaling through mitochondria and NFE2L2/ARE pathway. Sci Rep 2015 5 14368. doi: 10.1038/srep14368
195. Rafehi H, Balcerczyk A, Lunke S, Vascular histone deacetylation by pharmacological HDAC inhibition. Genome Res 2014 24 1271 1284. doi: 10.1101/gr.168781.113
196. Choi JH, Nam KH, Kim J, Baek MW, Park JE, Park HY, Kwon HJ, Kwon OS, Kim DY, Oh GT, Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 2005 25 2404 2409. doi: 10.1161/01.ATV.0000184758.07257.88
197. Zampetaki A, Zeng L, Margariti A, Xiao Q, Li H, Zhang Z, Pepe AE, Wang G, Habi O, deFalco E, Cockerill G, Mason JC, Hu Y, Xu Q, Histone deacetylase 3 is critical in endothelial survival and atherosclerosis development in response to disturbed flow. Circulation 2010 121 132 142. doi: 10.1161/CIRCULATIONAHA.109.890491
198. Duivenvoorden R, Tang J, Cormode DP, A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation. Nat Commun 2014 5 3065. doi: 10.1038/ncomms4065
199. Tang J, Lobatto ME, Hassing L, Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation. Sci Adv 2015 1. pii: e1400223. doi: 10.1126/sciadv.1400223
200. Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, Shi Y, Segal E, Chang HY, Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010 329 689 693. doi: 10.1126/science.1192002
201. Reinius LE, Acevedo N, Joerink M, Pershagen G, Dahlén SE, Greco D, Söderhäll C, Scheynius A, Kere J, Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS One 2012 7 e41361. doi: 10.1371/journal.pone.0041361
202. Gomez D, Shankman LS, Nguyen AT, Owens GK, Detection of histone modifications at specific gene loci in single cells in histological sections. Nat Methods 2013 10 171 177. doi: 10.1038/nmeth.2332